Dr. Joseph MinhowChan

Dr. Joseph Minhow Chan, MD, PhD, is a board-certified medical oncologist and physician-scientist specializing in the treatment of lung cancer and the study of computational biology and single-cell genomics. He sees patients at the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, where he works alongside a multidisciplinary team of lung cancer specialists, nurses, pharmacists, and support staff. Dr. Chan completed his undergraduate studies in biomedical computation at Stanford University, followed by an MD/PhD at Columbia University College of Physicians and Surgeons, where his doctoral work focused on computational biology. He developed novel methods to model viral evolution topology and identify gene fusions in cancer, contributing to the identification of recurrent FGFR-TACC fusions in brain cancer, the first time this mutation was discovered in any cancer. This mutation is now an FDA-approved drug target in bladder and gallbladder cancer. He completed his residency in internal medicine at Weill Cornell Medical Center at NewYork-Presbyterian and his oncology fellowship at Memorial Sloan Kettering Cancer Center.